Quantitative Models and Construction 1. Model Name: Volume Model - **Model Construction Idea**: This model evaluates market timing based on trading volume dynamics[10][64] - **Model Evaluation**: The model currently signals a neutral stance for the short term[10][64] 2. Model Name: Low Volatility Model - **Model Construction Idea**: This model assesses market timing by analyzing low volatility trends in the market[10][64] - **Model Evaluation**: The model currently signals a neutral stance for the short term[10][64] 3. Model Name: Institutional Feature Model (Dragon-Tiger List) - **Model Construction Idea**: This model uses institutional trading features from the Dragon-Tiger list to predict market movements[10][64] - **Model Evaluation**: The model currently signals a bearish outlook for the short term[10][64] 4. Model Name: Feature Volume Model - **Model Construction Idea**: This model leverages specific volume features to predict market trends[10][64] - **Model Evaluation**: The model currently signals a bearish outlook for the short term[10][64] 5. Model Name: Intelligent CSI 300 Model - **Model Construction Idea**: This model applies intelligent algorithms to predict movements in the CSI 300 index[10][64] - **Model Evaluation**: The model currently signals a bullish outlook for the short term[10][64] 6. Model Name: Intelligent CSI 500 Model - **Model Construction Idea**: This model applies intelligent algorithms to predict movements in the CSI 500 index[10][64] - **Model Evaluation**: The model currently signals a bearish outlook for the short term[10][64] 7. Model Name: Limit-Up/Down Model - **Model Construction Idea**: This model evaluates market timing based on the frequency of limit-up and limit-down events[11][65] - **Model Evaluation**: The model currently signals a bullish outlook for the mid-term[11][65] 8. Model Name: Calendar Effect Model - **Model Construction Idea**: This model incorporates calendar-based patterns to predict market movements[11][65] - **Model Evaluation**: The model currently signals a neutral stance for the mid-term[11][65] 9. Model Name: Long-Term Momentum Model - **Model Construction Idea**: This model evaluates long-term market trends using momentum indicators[12][66] - **Model Evaluation**: The model currently signals a neutral stance across all broad-based indices for the long term[12][66] 10. Model Name: A-Share Comprehensive Weapon V3 Model - **Model Construction Idea**: This model integrates multiple signals to provide a comprehensive market timing prediction[13][67] - **Model Evaluation**: The model currently signals a bearish outlook for the A-share market[13][67] 11. Model Name: A-Share Comprehensive CSI 2000 Model - **Model Construction Idea**: This model focuses on the CSI 2000 index, combining various timing signals[13][67] - **Model Evaluation**: The model currently signals a neutral stance for the A-share market[13][67] 12. Model Name: Turnover-to-Volatility Model (Hong Kong Market) - **Model Construction Idea**: This model evaluates market timing in the Hong Kong market by analyzing turnover relative to volatility[14][68] - **Model Evaluation**: The model currently signals a bullish outlook for the mid-term[14][68] --- Model Backtesting Results 1. Volume Model - **Short-Term Signal**: Neutral[10][64] 2. Low Volatility Model - **Short-Term Signal**: Neutral[10][64] 3. Institutional Feature Model (Dragon-Tiger List) - **Short-Term Signal**: Bearish[10][64] 4. Feature Volume Model - **Short-Term Signal**: Bearish[10][64] 5. Intelligent CSI 300 Model - **Short-Term Signal**: Bullish[10][64] 6. Intelligent CSI 500 Model - **Short-Term Signal**: Bearish[10][64] 7. Limit-Up/Down Model - **Mid-Term Signal**: Bullish[11][65] 8. Calendar Effect Model - **Mid-Term Signal**: Neutral[11][65] 9. Long-Term Momentum Model - **Long-Term Signal**: Neutral across all broad-based indices[12][66] 10. A-Share Comprehensive Weapon V3 Model - **Comprehensive Signal**: Bearish[13][67] 11. A-Share Comprehensive CSI 2000 Model - **Comprehensive Signal**: Neutral[13][67] 12. Turnover-to-Volatility Model (Hong Kong Market) - **Mid-Term Signal**: Bullish[14][68]

行业研究 非银行金融 2025 年 06 月 07 日 证 券 研 究 报 告 金融资金面跟踪：量化周报（2025/06/02~2025/06/06） 推荐（维持） 成交量有所提升，基差总体有所收敛 华创证券研究所 证券分析师：徐康 电话：021-20572556 邮箱：xukang@hcyjs.com 执业编号：S0360518060005 证券分析师：刘潇伟 邮箱：liuxiaowei@hcyjs.com 执业编号：S0360525020001 上周量化私募总体正超额。上周样本量化私募收益及超额如下：1）300 增强策略周 /月/年初以来平均收益分别为-0.4%/+3%/+1.3%，周/月/年初以来平均超额分别为 +0.6%/+1%/+4.5%；2）500 增强策略周/月/年初以来平均收益分别为+0.7%/+3.5%/+5.6%， 周/月/年初以来平均超额分别为+0.2%/+2.4%/+9.4%；3）A500 增强策略周/月/年初以来平 均收益分别为-0.4%/+3.1%/+8.9%，周/月/年初以来平均超额分别为+0.6%/+1.3%/+12.5%； 4）1000 增强策略周/月/年初以来平均收益分别为 ...

Employment Data Summary - In May, the U.S. added 139,000 non-farm jobs, slightly exceeding the expectation of 130,000[2] - Job growth was concentrated in three sectors: education and healthcare services (+87,000), leisure and hospitality (+48,000), and finance (+13,000)[2] - The unemployment rate remained steady at 4.2%, with a slight increase in the labor force participation rate from 62.6% to 62.4%[4] Wage Growth Insights - Hourly wage growth was 0.4% month-on-month, surpassing the expected 0.3%, and year-on-year growth was 3.9%, up from a revised 3.8%[3] - The average weekly hours worked remained at 34.3 hours, indicating stable labor income growth[3] - Wage growth is crucial for protecting consumer purchasing power, especially for low- and middle-income groups, amid inflation concerns[5] Market Reactions and Economic Outlook - Market expectations for interest rate cuts have cooled, with the probability of a September rate cut dropping from 61.3% to 51.8%[3] - The anticipated number of rate cuts for the year decreased from 2.1 to 1.8, and the year-end policy rate expectation rose from 3.795% to 3.886%[3] - Following the report, U.S. stock indices rose, with the Dow Jones up 1.05% and the Nasdaq up 1.2%, indicating a rebound in risk appetite[3]

Employment Data Summary - In May, the U.S. added 139,000 non-farm jobs, slightly exceeding the expectation of 130,000[2] - Job growth was concentrated in three sectors: education and healthcare services (+87,000), leisure and hospitality (+48,000), and finance (+13,000) while other sectors experienced job losses[2][25] - The unemployment rate remained steady at 4.2%, with a slight increase in the labor force participation rate dropping from 62.6% to 62.4%[4][29] Wage Growth Insights - Hourly wage growth was 0.4% month-over-month, surpassing the expected 0.3%, and year-over-year growth was 3.9%, up from a revised 3.8%[3][34] - The increase in wages is crucial for protecting the purchasing power of low- and middle-income consumers amid inflation concerns[5][19] Market Reactions - Market expectations for interest rate cuts have cooled, with the probability of a September rate cut dropping from 61.3% to 51.8%[3][39] - Following the employment report, U.S. stock indices rose, with the Dow Jones up 1.05%, Nasdaq up 1.2%, and S&P 500 up 1.03%[3][39] Employment Trends - The employment diffusion index fell to 50% for the month, indicating a decline in the breadth of job growth across sectors[4][24] - The total number of jobs added in the previous two months was revised down by 95,000, indicating a trend of slowing job growth[2][21]

Investment Rating - The industry investment rating is "Recommended," indicating an expected increase in the industry index by more than 5% over the next 3-6 months compared to the benchmark index [21]. Core Insights - The insurance index rose by 1.03%, outperforming the market by 0.15 percentage points, with notable individual stock performances such as Xinhua (+5.94%) and Taiping (+5.64%) [2]. - China Ping An plans to issue HKD 11.765 billion in convertible bonds, with an initial conversion price of HKD 55.02 per share, aimed at supporting business development and capital needs [3][4]. - As of Q1 2025, Ping An's solvency ratios were 225% for comprehensive solvency and 189% for core solvency, indicating a strong capital position [5]. Summary by Sections Market Performance - The insurance sector showed a mixed performance with individual stocks varying significantly, where Xinhua and Taiping led the gains while Sunshine and Zhong An faced declines [2]. - The 10-year government bond yield was 1.65%, down by 2 basis points from the previous week [2]. Company Developments - China Taiping announced a new private equity fund with a target size of RMB 50 billion, focusing on state-owned enterprise reforms [3]. - Ping An Asset Management received regulatory approval to establish a private fund management company, targeting a first-phase fund size of RMB 30 billion [3]. Financial Metrics - As of June 3, 2025, the closing price of Ping An's H shares was HKD 46.45, with the proposed convertible bond's conversion price exceeding this by HKD 18.45, reflecting confidence in future stock price growth [5]. - The new business value (NBV) for Ping An increased by 35% year-on-year, with significant growth expected from the bancassurance channel [5]. Investment Recommendations - The report suggests a cautious outlook for the short term due to performance pressures but anticipates a recovery in the medium to long term as the industry adapts to interest rate changes and improves operational quality [5]. - Current price-to-earnings (PE) and price-to-book (PB) ratios for key companies are provided, with Ping An rated at 1.04 PB and a strong buy recommendation [10].

Investment Rating - The report maintains an optimistic outlook on the pharmaceutical industry, particularly focusing on the potential growth in the gout medication market and ongoing drug development [11][18]. Core Insights - The pharmaceutical sector is currently undervalued, with public funds showing low allocation to this sector. The report anticipates a recovery driven by macroeconomic factors and significant product launches in the industry by 2025 [11]. - The report emphasizes the importance of innovative drugs, particularly in the gout treatment space, highlighting the shift from quantity to quality in drug development [11][20]. - The report identifies several key companies and products to watch, including innovative drug developers and medical device manufacturers, suggesting a diversified investment approach [11][12][18]. Summary by Sections Market Overview - The report notes that the CITIC pharmaceutical index rose by 1.22%, outperforming the CSI 300 index by 0.34 percentage points, ranking 16th among 30 sectors [8]. - The top-performing stocks in the pharmaceutical sector include Yiming Pharmaceutical and Wanbangde, while the worst performers include Longjin Retreat and Huasen Pharmaceutical [8]. Gout Treatment Market - The report highlights the significant market potential for gout medications, with a projected market size of approximately 1.821 billion yuan in 2024. The report notes that the market for febuxostat is expected to decline due to its inclusion in national procurement [20]. - The report outlines the two main therapeutic approaches for gout: inhibiting uric acid production and promoting uric acid excretion, with key drugs identified for each approach [20][21]. Innovative Drug Development - The report provides an overview of ongoing clinical trials for gout medications, particularly focusing on URAT1 inhibitors, which are currently the most promising targets in drug development [22][35]. - It highlights the progress of SHR4640, a URAT1 inhibitor developed by Hengrui Medicine, which has shown promising results in clinical trials and is expected to be the first domestic URAT1 inhibitor to be approved [26]. Medical Devices and Equipment - The report discusses the recovery of the medical device market, particularly imaging equipment, which is expected to see significant growth due to ongoing procurement processes and government subsidies [42]. - It emphasizes the importance of domestic manufacturers in the medical device sector, particularly in the context of increasing competition and the need for innovation [42][43]. Investment Recommendations - The report suggests focusing on companies with strong pipelines and innovative products, including those in the pharmaceutical and medical device sectors, to capitalize on the anticipated growth in the industry [11][12][41].

Investment Rating - The report maintains an optimistic outlook on the pharmaceutical industry, particularly focusing on the potential growth in the gout medication market and ongoing drug development [11]. Core Insights - The pharmaceutical sector is currently undervalued, with public funds showing low allocation to this sector. The report anticipates a recovery driven by macroeconomic factors and significant product launches in the industry by 2025 [11]. - The report emphasizes the importance of innovative drugs, particularly those that can transition from quantity to quality, highlighting the need to focus on differentiated products and international pipelines [11]. - The gout medication market is identified as a "blue ocean" with significant growth potential, driven by the high prevalence of hyperuricemia and gout in China [18][20]. Market Overview - The report notes that the overall prevalence of hyperuricemia in China is approximately 13.3%, affecting around 177 million people, while gout affects about 14.66 million individuals [17]. - The market for gout medications is projected to reach approximately 1.821 billion yuan in 2024, with significant contributions from drugs like febuxostat and probenecid [20]. Drug Development Landscape - The report outlines the current landscape of gout treatments, categorizing them into two main mechanisms: uric acid synthesis inhibitors and uric acid excretion promoters [20]. - Several innovative drugs are in various stages of clinical development, with a focus on URAT1 inhibitors, which are currently the most promising targets in gout treatment [21][22]. - The report highlights the progress of SHR4640, a URAT1 inhibitor developed by Heng Rui Medicine, which has shown promising results in clinical trials and is expected to be the first domestic URAT1 inhibitor to be approved [26]. Investment Opportunities - The report suggests focusing on companies with strong pipelines in innovative drug development, particularly those targeting gout and related conditions, such as BeiGene, Innovent, and others [11]. - It also recommends monitoring the progress of medical device companies that are benefiting from policy support and market recovery, particularly in imaging and home healthcare devices [42][43]. Conclusion - The report concludes that the pharmaceutical and medical device sectors present significant investment opportunities, driven by innovation, market recovery, and favorable demographic trends [11][42].

1. Report Industry Investment Rating Not mentioned in the content. 2. Core View of the Report In May 2025, with the implementation of double cuts and the coordination of multiple tools by the central bank, the capital market remained stable, and the DR007 capital center declined. In June, although there is a liquidity gap, the pre - operation of the outright reverse repurchase and the central bank's usual care during the half - year period are expected to keep the risk of significant capital convergence relatively controllable, and the DR007 price is expected to be in the range of 1.5 - 1.65% [1][3]. 3. Summary According to the Directory 3.1 May Capital and Liquidity Review: Double Cuts Implemented, Capital Center Declined 3.1.1 Capital Review: Slightly Enlarged Capital Fluctuation Range In May 2025, the central bank coordinated multiple tools. After the double cuts, the capital price decreased, and the DR007 capital center dropped from 1.7% to around 1.6%. The fluctuation range of overnight and 7D weighted prices increased. The spread between 7D and overnight funds widened from 2bp at the beginning of the month to 18bp at the end of the month without inversion. The capital stratification pressure was small, and the volatility was at a low level. The trading volume and average daily trading volume of inter - bank pledged repurchase increased slightly compared with April. The net lending scale of state - owned banks recovered, while that of joint - stock banks was at a seasonal low, and the net lending of money market funds declined [8][9][14]. 3.1.2 Liquidity Review: Reserve Requirement Cut, Bank Liquidity Increased The end - of - month excess reserve may increase by 93.84 billion yuan, and the excess reserve ratio may be around 1.3%. The narrow - sense excess reserve level after deducting reverse repurchases may be around 0.7%, still at a relatively low seasonal level. In terms of open - market operations, the central bank actively increased reverse - repurchase investments. MLF had a net investment of 37.5 billion yuan, and the outright reverse - repurchase had a net withdrawal of 20 billion yuan. There was no restart of treasury bond purchases, and treasury deposits were issued for 24 billion yuan [28][33][41]. 3.2 May Monetary Policy Tracking: "Steady Growth" Priority, Double Cuts Implemented in May In May 2025, the double cuts were implemented slightly ahead of market expectations. After the double cuts in the first ten - day period, the capital price decreased. In the middle and last ten - day periods, the central bank gradually shifted from net withdrawal to large - scale net investment. At the end of the month, various tools were used to support the market. The pre - operation of the outright reverse repurchase in June helps stabilize capital expectations. Policy tools include comprehensive use of reserve requirement cuts, interest rate cuts, and adjustments to structural monetary policy tools [46][49][52]. 3.3 June Gap Forecast: Pre - operation of Outright Reverse Repurchase, Limited Capital Gap Pressure 3.3.1 Rigid Gap: Reserve Requirement Releases Excess Reserves, Large - scale Maturity of Outright Reverse Repurchases In June, the reserve requirement for general deposit growth may freeze around 22.56 billion yuan of liquidity, and the MLF maturity is 18.2 billion yuan. The outright reverse - repurchase maturity is 1.2 trillion yuan, with 1 trillion yuan already pre - operated [3][58]. 3.3.2 Exogenous Shocks: Cash Withdrawal and Non - financial Institution Deposits Have a Small Impact on Excess Reserves Cash withdrawal and non - financial institution deposits may slightly consume around 11.52 billion yuan of liquidity [3][60]. 3.3.3 Fiscal Factors: Large - scale Government Bond Issuance, Fiscal Expenditure Concentrated at the End of the Quarter The government deposit may supplement around 40 billion yuan of liquidity, slightly lower than last year's level [3][64]. 3.3.4 Comprehensive Judgment: Pre - operation of Outright Reverse Repurchase, Relatively Stable Capital The total liquidity gap in June is around 1.4 trillion yuan. Considering the 1 - trillion - yuan outright reverse - repurchase already invested, the overall capital gap pressure is relatively limited. The central bank usually provides support during the half - year period, and the DR007 price is expected to be in the range of 1.5 - 1.65% [3][65][69].

Investment Rating - The report maintains a "Strong Buy" rating for Huamao Technology (603306) [1] Core Views - The acquisition plan exceeds expectations, with Huamao Technology's major shareholder subscribing to supporting funds, demonstrating confidence in the company's performance [1] - The company plans to acquire the remaining equity of Fuchuang Youyue, increasing its ownership from 42.16% to 100% [1] - Fuchuang Youyue is expected to achieve a net profit of 0.78 billion yuan from January to April 2025 [1] Financial Summary - Total revenue projections for 2024A, 2025E, 2026E, and 2027E are 2,213 million, 2,908 million, 3,494 million, and 4,186 million yuan respectively, with year-on-year growth rates of 7.7%, 31.4%, 20.2%, and 19.8% [3] - Net profit attributable to the parent company is forecasted to be 277 million, 590 million, 748 million, and 934 million yuan for the same years, with growth rates of 14.6%, 112.7%, 26.8%, and 24.8% [3] - Earnings per share (EPS) are projected at 0.84, 1.79, 2.27, and 2.84 yuan for 2024A to 2027E [3] - The target price is set at 51.28 yuan, with the current price at 40.15 yuan [4] Business Insights - The company is positioned as a leader in the domestic automotive passive safety market, with significant overseas expansion plans [8] - The global airbag market exceeds 10 billion USD, and the increasing configuration rate of airbags per vehicle is expected to drive market growth [8] - The company has established a new base in Vietnam, which is expected to contribute significantly to revenue starting in 2025 [8] - The company is actively investing in the AI sector, with plans to enhance its capabilities in semiconductor and computing power manufacturing [8]

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - The overall operation of industrial bond - issuing entities was under pressure in 2024, with differentiated industry performance. The total operating revenue and net profit of industrial bond entities decreased year - on - year, and the proportion of loss - making enterprises increased. In 2025Q1, the overall operating revenue of industrial bond entities decreased year - on - year, while the net profit remained flat. [2][3] - The economic fundamentals are expected to continue the characteristics of domestic demand support, external demand pressure, and policy escort this year. Attention should be paid to the improvement of the fundamentals of entities under the influence of pro - growth policies. [2][13] - For the real estate industry, it is still in the bottom - building stage. Attention can be paid to the income - mining opportunities of central and state - owned enterprise real estate bonds with an implied rating of AA and above within 1 - 2 years. [4] - For the coal industry, there is downward pressure on the industry's prosperity. Short - term medium - and high - grade varieties can be focused on, and institutions with higher income requirements can appropriately invest in 1 - 2y varieties of coal enterprises with an implied rating of AA. [5] - For the steel industry, the problem of over - supply is still serious. Caution should be exercised when investing in lower - quality entities, and 1 - 2yAA + varieties can be focused on. [6] 3. Summary According to the Directory 3.1. How Did the Annual Reports and Q1 Reports of Each Industry Perform? 3.1.1. Overall Situation Analysis: The Overall Profitability Declined - In 2024, the total operating revenue and net profit of industrial bond entities decreased year - on - year, and the proportion of loss - making enterprises increased from 18% in 2023 to 21% in 2024. [13][14] - In 2025Q1, the overall operating revenue of industrial bond entities decreased by 2% year - on - year, while the net profit remained flat. [15] 3.1.2. Industry Performance: A Minority of Industries Had Positive Revenue and Net Profit Growth, and Most Industries Had Positive Growth in Operating Net Cash Flow - In 2024, about one - third of industries had positive revenue growth, and about 40% of industries had positive net profit growth. Nearly half of the industries had an increase in asset - liability ratio, and about 60% of industries had positive growth in operating net cash flow. [3] - Industries with revenue growth of over 5% in 2024 included non - ferrous metals, electronics, etc.; industries with a decline of over 5% included coal, steel, etc. [20] 3.1.3. Situations of Continuously Loss - making and Turnaround Entities - There were 79 bond - issuing industrial entities with net profit losses for 3 consecutive years or more, mainly distributed in transportation, real estate, etc. [36] - There were 20 bond - issuing industrial entities that had net profit losses for 2 consecutive years or more and turned profitable in 2024, mainly in public utilities, social services, etc. [39] 3.2. Financial Analysis of Key Industries: Real Estate, Coal, and Steel 3.2.1. Real Estate Industry: The Industry Is Still in the Bottom - building Stage, and Attention Should Be Paid to the Investment Opportunities of Central and State - owned Enterprises within 1 - 2 Years - **Fundamentals**: Pro - real - estate policies have been actively implemented, and the effect of destocking policies is gradually emerging, but the industry's prosperity is still low. [41] - **Financial Indicator Performance**: The profitability is under continuous pressure, the operating net cash flow is stable, the gaps in investment and financing net cash flows are narrowing, the median asset - liability ratio has decreased slightly, and the short - term solvency has declined. [4][50][51] - **Investment Strategy**: Attention can be paid to the income - mining opportunities of central and state - owned enterprise real estate bonds with an implied rating of AA and above within 1 - 2 years. Some 1 - year central and state - owned enterprise real estate bonds with an implied rating of AA and AA + have yields ranging from 2.2% to 2.7%. [4][61] 3.2.2. Coal Industry: There Is Downward Pressure on the Industry's Prosperity, and Attention Should Be Continuously Paid. Currently, Appropriate Investment in Lower - Grade Entities Can Be Made - **Fundamentals**: Since last year, there has been downward pressure on the coal industry's prosperity. Supply is sufficient but demand is weak, and coal prices have fluctuated downward. There may still be some downward pressure on coal prices this year. [5][63] - **Financial Indicator Performance**: The overall profitability has declined, the operating net cash flow has shrunk, the gap in investment cash flow has widened, the gap in financing cash flow has narrowed, the median asset - liability ratio has decreased, and the short - term solvency has declined. [5][68][71] - **Investment Strategy**: Short - term medium - and high - grade varieties can be focused on. Institutions with higher income requirements can appropriately invest in 1 - 2y varieties of coal enterprises with an implied rating of AA, and medium - and high - grade entities can extend the duration to 3y. [5][77] 3.2.3. Steel Industry: The Problem of Over - Supply in the Industry Is Still Serious. Caution Should Be Exercised When Investing in Lower - Quality Entities - **Fundamentals**: Since 2024, the steel industry has been in the bottom - exploring stage. Although the pro - growth policies have slightly improved the industry's prosperity, the sustainability is weak. The problem of over - supply is still serious. [6] - **Financial Indicator Performance**: The profitability has been under continuous pressure, with a marginal improvement in Q1. The operating net cash flow has shrunk, the gap in investment net cash flow has widened, the financing net cash flow has turned positive, the median asset - liability ratio has increased, and the short - term solvency has slightly declined. [6] - **Investment Strategy**: Caution should be exercised when investing in lower - quality entities. 1 - 2yAA + varieties can be focused on. [6]